American Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Buy
+3,781
New +$362K 0.03% 213
2024
Q2
Sell
-10,028
Closed -$874K 283
2024
Q1
$874K Sell
10,028
-835
-8% -$71.3K 0.07% 101
2023
Q4
$895K Buy
10,863
+296
+3% +$22.6K 0.07% 100
2023
Q3
$828K Sell
10,567
-2,763
-21% -$231K 0.06% 113
2023
Q2
$1.17M Sell
13,330
-215
-2% -$18.5K 0.08% 124
2023
Q1
$1.09M Sell
13,545
-5,009
-27% -$408K 0.08% 128
2022
Q4
$1.44M Sell
18,554
-1,125
-6% -$91.2K 0.13% 111
2022
Q3
$1.59M Sell
19,679
-1,998
-9% -$180K 0.13% 105
2022
Q2
$1.95M Sell
21,677
-66
-0.3% -$6.69K 0.16% 98
2022
Q1
$2.41M Buy
21,743
+17,174
+376% +$1.81M 0.16% 94
2021
Q4
$473K Buy
+4,569
New +$529K 0.04% 169

Other funds holding MDT

American Trust's MDT Position: Q1 2026 in Review

American Trust opened a new position in Medtronic (MDT) in Q1 2026: 3,781 shares worth $328K. The stake represents 0.03% of the portfolio and ranks #213 among its holdings. This is a return to the name: American Trust previously reported a position in MDT as recently as Q1 2024.

American Trust first reported a position in MDT in Q4 2021 and has held it in 11 quarters since. The position peaked at $2.41M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • American Trust held 3,781 shares of Medtronic worth $328K as of Q1 2026.
  • Medtronic was a new American Trust position in Q1 2026.
  • Medtronic made up 0.03% of American Trust's portfolio in Q1 2026, its #213 holding.
  • American Trust first reported a position in Medtronic in Q4 2021 and has held it in 11 quarters since.
  • American Trust's Medtronic position peaked at $2.41M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.